Related Experiment Videos
Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen
Cheng-Yuan Huang1, Desiree A Thayer, Aileen Y Chang
1Department of Chemistry and The Skaggs Institute for Chemical Biology, and Array Core Facility, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Summary
Researchers synthesized cancer antigen Globo H hexasaccharide and its fragments for improved diagnostics. The study reveals key binding specificities for monoclonal antibodies and patient serum, offering a sensitive platform for monitoring immune responses.
Area of Science:
- Carbohydrate Chemistry
- Glycobiology
- Immunology
Background:
- Cell-surface carbohydrate interactions with antibodies and receptors are crucial for developing targeted therapeutics and sensitive diagnostics.
- Current methods are limited by the availability of natural oligosaccharides and assay sensitivity.
- The cancer antigen Globo H hexasaccharide is a key epitope on various cancer cell surfaces.
Purpose of the Study:
- To synthesize Globo H hexasaccharide and its truncated sequences using a programmable one-pot strategy.
- To develop a sensitive platform for analyzing antibody and serum binding specificities.
- To define the binding requirements of monoclonal antibodies and patient serum to Globo H epitopes.
Main Methods:
- Programmable one-pot synthesis of Globo H hexasaccharide and truncated sequences.
- Covalent arraying of synthesized saccharides on glass slides at varying densities.
- Fluorescence-based binding analysis using monoclonal antibodies and breast cancer patient serum.
Main Results:
- The terminal tetrasaccharide of Globo H binds monoclonal antibodies as effectively as the full hexasaccharide.
- The fucose residue is essential for effective binding of monoclonal antibodies.
- Patient serum showed similar binding to both fucosylated hexasaccharide and defucosylated pentasaccharide.
Conclusions:
- The developed method is highly sensitive and requires minimal material, outperforming traditional ELISA.
- This platform enables precise monitoring of immune responses to carbohydrate epitopes during cancer progression and treatment.
- Understanding Globo H binding specificities can inform the development of novel cancer diagnostics and therapeutics.